Cell Line Development Market Report: Trends, Forecast and Competitive Analysis to 2030

Cell Line Development Trends and Forecast

The future of the global cell line development market looks promising with opportunities in the bioproduction, drug discovery, toxicity testing, and tissue engineering applications. The global cell line development market is expected to reach an estimated $9.6 billion by 2030 with a CAGR of 9.4% from 2024 to 2030. The major drivers for this market are growing worldwide demand for monoclonal antibodies and increasing need for vaccine development.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Cell Line Development by Segment

The study includes a forecast for the global cell line development by product & service, source, type of cell line, application, and region.

Cell Line Development Market by Product & Service [Shipment Analysis by Value from 2018 to 2030]:

• Reagents and Media
• Equipment
• Accessories & Consumables
• Services

Cell Line Development Market by Source [Shipment Analysis by Value from 2018 to 2030]:

• Mammalian Cell Line
• Non-Mammalian Cell Line

Cell Line Development Market by Type of Cell Line [Shipment Analysis by Value from 2018 to 2030]:

• Recombinant Cell Lines
• Hybridomas
• Continuous Cell Lines
• Primary Cell Lines

Cell Line Development Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Bioproduction
• Drug Discovery
• Toxicity Testing
• Tissue Engineering
• Others

Cell Line Development Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cell Line Development Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cell line development companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cell line development companies profiled in this report include-

• Thermo Fisher Scientific
• Corning
• Lonza
• Creative BioLabs
• WuXi PharmaTech
• Sartorius
• Merck
• Advanced Instruments
• Berkeley Lights
• Danaher

Cell Line Development Market Insights

Lucintel forecasts that reagent and media will remain the largest segment over the forecast period due to its wide ranging uses in various fields, such as bioproduction, tissue engineering, regenerative medicine, drug discovery, and toxicity testing.

Within this market, bioproduction will remain the largest segment due to increased need for pharmaceuticals and vaccine production.

North America will remain the largest region over the forecast period due to availability of advanced healthcare infrastructure, rising awareness related to cell therapy, and presence of key players in the region.

Features of the Global Cell Line Development Market

Market Size Estimates: Cell line development market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cell line development market size by various segments, such as by product & service, source, type of cell line, application, and region in terms of value ($B).

Regional Analysis: Cell line development market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & services, sources, type of cell lines, applications, and regions for the cell line development market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cell line development market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cell line development market size?

Answer: The global cell line development market is expected to reach an estimated $9.6 billion by 2030.

Q2. What is the growth forecast for cell line development market?

Answer: The global cell line development market is expected to grow with a CAGR of 9.4% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the cell line development market?

Answer: The major drivers for this market are growing worldwide demand for monoclonal antibodies and increasing need for vaccine development.

Q4. What are the major segments for cell line development market?

Answer: The future of the cell line development market looks promising with opportunities in the bioproduction, drug discovery, toxicity testing, and tissue engineering applications.

Q5. Who are the key cell line development market companies?

Answer: Some of the key cell line development companies are as follows:

• Thermo Fisher Scientific
• Corning
• Lonza
• Creative BioLabs
• WuXi PharmaTech
• Sartorius
• Merck
• Advanced Instruments
• Berkeley Lights
• Danaher

Q6. Which cell line development market segment will be the largest in future?

Answer: Lucintel forecasts that reagent and media will remain the largest segment over the forecast period due to its wide ranging uses in various fields, such as bioproduction, tissue engineering, regenerative medicine, drug discovery, and toxicity testing.

Q7. In cell line development market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to availability of advanced healthcare infrastructure, rising awareness related to cell therapy, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cell line development market by product & service (reagents and media, equipment, accessories & consumables, and services), source (mammalian cell line and non-mammalian cell line), type of cell line (recombinant cell lines, hybridomas, continuous cell lines, and primary cell lines), application (bioproduction, drug discovery, toxicity testing, tissue engineering, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?